Abstract
There is increasing interest in unattended automated office blood pressure (OBP) measurement, which gives lower blood pressure values than the conventional auscultatory OBP. Whether unattended automated OBP differs from standardized attended automated OBP performed using the same device and measurement protocol remains uncertain. A systematic review and meta‐analysis of studies (aggregate data) comparing unattended vs attended automated OBP using the same device and measurement protocol (conditions, number of measurements, visits) was performed. Ten eligible studies (n = 1004, weighted age 60.8 ± 4.2 [SD] years, 55% males) were analyzed. Unattended OBP (pooled systolic/diastolic 133.9 [95% CI: 129.7, 138]/80.6 [95% CI: 77, 84.2] mm Hg) did not differ from attended OBP (135.3 [95% CI: 130.9, 139.6]/81 [95% CI: 77.6, 84.3] mm Hg); pooled systolic OBP difference −1.3, 95% CI: −4.3, 1.7 mm Hg and diastolic −0.4, 95% CI: −1.2, 0.3 mm Hg. Nine of ten studies achieved high quality score and no publication bias was identified. Meta‐regression analysis did not reveal any effect of age, gender, or attended systolic OBP on the unattended‐attended systolic OBP difference (P = NS for all). However, there was a trend toward higher attended than unattended OBP at higher OBP levels. These data suggest that, when the same device and measurement protocol are used, attended automated OBP provides similar blood pressure values as unattended automated OBP. Although unattended automated OBP is theoretically advantageous as it ensures that standardized conditions and measurement protocol are used, attended automated OBP, if carefully performed, appears to be a reasonable and practical alternative.
Keywords: clinic blood pressure, electronic, methodology, observer, unobserved
1. INTRODUCTION
For almost a century, office blood pressure (OBP) measurement has been regarded as the cornerstone for treatment decisions in hypertension.1, 2 This is because the vast majority of the evidence regarding the cardiovascular risk associated with elevated blood pressure (BP) and the benefits of the treatment‐induced BP lowering have been based on OBP measurements.3 However, it is recognized that OBP is a “weak” cornerstone, mainly due to the white‐coat and the masked hypertension phenomena, observer‐related issues, such as observer error and bias, and unstandardized conditions and protocol of measurements.1, 2
To eliminate the observer factor in OBP measurement, validated automated BP monitors are being increasingly used in clinical research and practice. Several years ago, Myers et al introduced the concept of “unattended automated OBP” measurement with multiple automated OBP measurements taken while the patient is resting alone in the examination room (no presence of physician or nurse).4, 5 Studies have shown that unattended OBP appears to be lower than conventional auscultatory OBP and similar to awake ambulatory BP and reduces the prevalence of white‐coat hypertension.4, 5
In the Systolic BP Intervention Trial (SPRINT), both unattended and attended automated OBP measurements were performed using the same device and measurement protocol but in different patients, and no difference between the two methods was found in average follow‐up OBP as well as in cardiovascular risk decline in the intensively treated group.6 In a recent editorial which accompanied the SPRINT OBP measurement analysis report,6 we presented a review of previous studies comparing unattended vs attended OBP using automated devices and showed no difference between them.1 However, this review was not systematic and meta‐analysis of the data was not performed.1
This article presents a systematic review and meta‐analysis of the published evidence on the difference between unattended and attended OBP from studies that applied the two methods in the same patients using the same device, conditions, and measurement protocol.
2. METHODS
2.1. Search strategy
A systematic literature search was performed independently by three investigators (ES, KGK, and AG) at PubMed and EMBASE databases using the following search keywords: (("blood pressure") AND (office OR clinic)) AND (unattended OR unobserved OR automated OR electronic). For the EMBASE search, guided mapping of keywords to abstract/title/Emtree indexing terms was applied. Articles were also selected from references of relevant articles. Disagreements were resolved by consensus with a senior author (AK).
2.2. Selection criteria, data extraction, and statistical analysis
A systematic review was performed in line with the PRISMA recommendations ( www.prisma-statement.org). Eligible studies were full‐text articles written in English with comparative data on unattended vs attended OBP measurements that (1) were performed in the same subjects, (2) used the same device and methodology (conditions, protocol and number of measurements and visits), and (3) reported the OBP difference between the two methods.
2.3. Assessment of methodologic quality
The quality of the studies was assessed in terms of selection bias, detection bias, accuracy of measurement, analysis, and confounding using a combination of questions from the QUADAS‐2 and CASP checklists for assessing cohort studies.7, 8 Studies fulfilling ≥4 of the quality domains were deemed as high quality. Because of the strict methodological criteria for study inclusion in the meta‐analysis, mainly high‐quality studies were expected to be included.
2.4. Statistical analysis
Meta‐analysis was performed based on aggregate data from selected studies for pooling the outcome of interest, which was the mean OBP difference with 95% confidence interval (CI) between unattended and attended measurements. Random rather than fixed effects models were performed as more appropriate for balancing weights across large and small studies and to allow for variation in study effects due to the expected dispersion in the effect size across studies (attributed to factors such as age, ethnicity, and methodology).9 Sensitivity and stratified analyses based on several criteria such as the quality of the included studies, exclusion of outlier studies, age, gender, average level of attended systolic OBP, type of the device used, rest period, number of readings, and protocol used were also performed. Meta‐analysis regression was performed using the Stata/SE 11.2, Texas, USA software. Heterogeneity was tested using I 2 statistics. Publication bias was evaluated using Begg's funnel plots and Begg's and Egger's statistical tests.10, 11 When average OBP difference was reported without its SD, the latter was calculated using the following formula:12
SD of difference =
SD1, SD of attended OBP; SD2, SD of unattended OBP; r, correlation coefficient between attended and unattended OBP.
In 2 studies in which this was not feasible, the average SD of the comparison groups was used. Summary descriptive statistics are presented as mean ± SD weighted by sample size, unless stated otherwise. Two‐sided P values <0.05 were considered significant.
3. RESULTS
The initial literature search identified 3783 potentially relevant articles. The flow diagram for articles’ selection procedure is presented in Figure 1. Twenty‐three studies were relevant for the review reporting unattended vs attended OBP data.6, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 In one study, data were modified after communication with the corresponding author.30 Thirteen of these studies were excluded because in comparing unattended with attended OBP they assessed different subjects with each method,6 obtained different number of readings,13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 had different number of visits,17, 18, 22 used a different BP monitor,13, 22 or used different methodology (rest time, intervals between measurements, position).13, 24 Ten studies fulfilled all the inclusion requirements for the meta‐analysis (n = 1004, weighted age 60.8 ± 4.2 [SD] years, 55% males) (Table 1).25, 26, 27, 28, 29, 30, 31, 32, 33, 34
Figure 1.

Flow chart for study selection
Table 1.
Studies comparing unattended vs attended automated office blood pressure measurements taken using the same devices and measurement protocol
| Study | N | Age (y) | Males (%) | Rest before readings; N of BP readings/visit; interval | Device type | Visits; Order of BP measurements | Attended BP | Unattended‐attended BP difference (95% CI) |
|---|---|---|---|---|---|---|---|---|
| Vinyoles et al25 | 106 | 65.7 | 44 | NR; 3; 2‐min | Omron HEM‐705CP | Same single visit; Random |
S: 137 ± 17.9 D: 80 ± 10 |
S: 2 (0.1, 3.9) D: 0 (−1.1, 1.1) |
| Stergiou et al26 | 30 | 48.9 | NR | 5‐min; 3; 1‐min; | Omron HEM‐705CP | 2 different separate visits per method; Randomized |
S: 139.3 ± 16.2 D: 89.2 ± 8.0 |
S: −1.9 (−4.1, 0.3) D: −1.6 (−3.3, 0.1) |
| Greiver et al27 | 50 | NR | NR | NR; 6; 1‐min | BpTRU | Same single visit; Random |
S: 121.1 ± 17.9 D: 73.9 ± 10.2 |
S: −1.8 (−3.6, 0.1) D: −0.8 (−2.5, 0.8) |
| Al‐Karkhi et al28 | 162 | 62.6 | 49 | 5‐min; 3; 1‐min | Omron i‐C10 (semiautomatic) | Same single visit; Random |
S: 139.1 ± 18 D: 84.8 ± 11 |
S: −1.1 (−2.6, 0.4) D: 1.1 (−0.1, 2.3) |
| Wang et al29 | 54 | 52.9 | 48 | 10‐min; 3; 1‐min | Omron HEM 7080‐IC | Same single visit; Randomized |
S: 146.6 ± 13.5 D: 91.3 ± 10.3 |
S: 0.2 (−3.7, 4.1) D: −0.3 (−3.0, 2.4) |
| Rinfret et al30 | 65 | 66.3 | 68 | 0‐min; 6; 1‐min | BpTRU | Same single visit; Attended first |
S: 127.4 ± 15.9 D: 72.6 ± 11.3 |
S: 1.2 (−0.4, 2.8) D: −0.5 (−1.4, 0.4) |
| Bauer et al31 | 51 | 65 | 59 | 5‐min; 3; 1‐min | Omron HEM‐907 | Same single visit; Random |
S: 135.7 ± 21.5 D: 80.6 ± 12.0 |
S: −1.5 (−3.5, 0.5) D: 0.0 (−1.4, 1.4) |
| Andreadis et al32 | 146 | 56 | 53 | 5‐min; 3; 1‐min | Omron HEM‐907 | Same single visit; Alternating sequence |
S: 129 ± 15 D: 78 ± 13 |
S: 0.6 (−0.3, 1.6) D: 0.2 (−0.5, 0.8) |
| Paini et al33 | 329 | 61 | 59 | 5‐min; 3; 1‐min | Omron HEM‐9000Ai | Same single visit; Random |
S: 138.4 ± 16.7 D: 79.3 ± 11.9 |
S: −8.6 (−9.4, −7.8) D: −2 (−2.6, −1.4) |
| Papademetriou et al34 | 11 | NR | NR | 5‐min; 3; 1‐min | Omron HEM‐907 | Same single visit; Alternating sequence |
S: 143.6 ± 28.3 D: 79.4 ± NR |
S:‐2.9 (−20, 14.2) D:‐1.4 (−10.7, 7.9) |
BP, blood pressure; CI, confidence intervals; D, diastolic BP (mean ± SD); NR, not reported; S, systolic BP.
Analysis of these studies revealed that the difference between unattended OBP (pooled value 133.9 [95% CI: 129.7, 138]/80.6 [95% CI: 77, 84.2] mm Hg, systolic/diastolic) and attended OBP (135.3 [95% CI: 130.9, 139.6]/81 [95% CI: 77.6, 84.3] mm Hg) was not statistically significant for systolic (pooled difference −1.3, 95% CI: −4.3, 1.7 mm Hg) or diastolic BP (−0.4, 95% CI: −1.2, 0.3 mm Hg) (Figure 2).
Figure 2.

Forest plot of pooled difference between unattended and attended systolic (A) and diastolic (B) office blood pressure [Colour figure can be viewed at wileyonlinelibrary.com]
All studies except one achieved high quality rating (Table 2) and no publication bias was identified in Begg's funnel plots (Supplementary Figure S1) and Egger's testing (P = NS for both systolic/diastolic OBP differences). However, in trim‐and‐fill analysis, the addition of three estimated unpublished studies rendered the summary estimate of the random effect model for systolic OBP difference significant to −2.6 (95% −4.9, −0.2) mm Hg, whereas no additional studies were identified for diastolic OBP difference (−0.4, 95% −1.2, 0.3 mm Hg) (Supplementary Figure S2).
Table 2.
Methodological quality of the included studies
| Study | Patient selection | Outcome measurement | Analysis | Confounding | Overall quality rating | ||
|---|---|---|---|---|---|---|---|
| Was patients’ selection appropriate? | Did the study avoid inappropriate exclusions? | Was the sample representative of the intended population? | Is the outcome variable measured appropriately? | Was the unattended vs. attended BP difference as primary endpoint? | Were important confounding factors identified in design or analysis (ie order effect)? | ||
| Vinyoles et al25 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Stergiou et al26 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Greiver et al27 | Yes | Yes | Yes | Yes | Yes | Yes | High |
| Al‐Karkhi et al28 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Wang et al29 | Yes | Unclear | Unclear | Unclear | Yes | Yes | Moderate |
| Rinfret et al30 | Yes | Yes | Unclear | Yes | Yes | No | High |
| Bauer et al31 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Andreadis et al32 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Paini et al33 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
| Papademetriou et al34 | Yes | Unclear | Unclear | Yes | Yes | Yes | High |
BP, blood pressure.
Sensitivity and stratified analyses based on several criteria are shown in Table 3. In all of these analyses, there were no significant systolic and/or diastolic OBP differences (Table 3). However, there was a trend for larger differences (lower unattended than attended OBP) for higher vs lower attended systolic OBP levels (Table 3).
Table 3.
Sensitivity and stratified analyses
| Type of analysis | Criterion | Studies included in the analysis | N of studies | Systolic BP difference | Diastolic BP difference |
|---|---|---|---|---|---|
| Sensitivity analyses | Quality of studies | High‐quality studies | 9 | −1.4 (−4.6, 1.7) | −0.5 (−1.3, 0.4) |
| Outlier studies | Exclusion of Paini et al | 9 | −0.2 (−1.2, 0.7) | −0.1 (−0.5, 0.4) | |
| Exclusion of Vinyoles et al | 9 | −1.7 (−4.9, 1.5) | −0.5 (−1.4, 0.4) | ||
| Stratified analyses | Age | >60 years | 5 | −1.6 (−6.4, 3.1) | −0.3 (−1.5, 0.8) |
| ≤60 years | 3 | −0.2 (−2.0, 1.5) | −0.4 (−1.6, 0.8) | ||
| Gender | Males >50% | 4 | −2.1 (−7.6, 3.4) | −0.6 (−1.8, 0.6) | |
| Males ≤50% | 3 | 0.3 (−1.9, 2.6) | 0.4 (−0.4, 1.2) | ||
| Attended systolic BP | >137 mm Hg | 5 | −3.0 (−7.7, 1.8) | −0.8 (−2.5, 0.9) | |
| ≤137 mm Hg | 5 | 0.2 (−1.1, 1.4) | −0.1 (−0.5, 0.4) | ||
| Device | Omron | 8 | −1.6 (−5.2, 2.1) | −0.4 (−1.4, 0.6) | |
| BpTRU | 2 | −0.3 (−3.2, 2.7) | −0.6 (−1.4, 0.2) | ||
| Rest period | Studies with reported rest period before measurements | 7 | −2.1 (−6.1, 1.8) | −0.5 (−1.6, 0.7) | |
| Studies without or with no reported rest period before measurements | 3 | 0.5 (−1.7, 2.7) | −0.4 (−1.0, 0.3) | ||
| Number of readings | 3 readings | 8 | −1.6 (−5.2, 2.1) | −0.4 (−1.4, 0.6) | |
| 6 readings | 2 | −0.3 (−3.2, 2.7) | −0.6 (−1.4, 0.2) | ||
| Protocol | SPRINT protocol (5‐min rest; 3 automated readings; 1‐min intervals) | 4 | −3.2 (−9.5, 3.2) | −0.7 (−2.3, 0.9) | |
| Other protocol | 6 | −0.3 (−1.6, 1.1) | −0.3 (−1.0, 0.5) |
BP, blood pressure.
Meta‐regression analysis did not reveal any effect of age, gender, or attended systolic OBP on the unattended‐attended systolic OBP difference (P = NS for all). However, there was again a trend toward a larger BP difference (lower unattended than attended OBP) at higher attended systolic OBP levels (Figure 3).
Figure 3.

Meta‐regression analysis of the effect of attended systolic office blood pressure on the unattended minus attended systolic office blood pressure difference
4. DISCUSSION
The main finding of this meta‐analysis of 10 studies is that unattended OBP and standardized attended automated OBP performed in the same subjects and using the same methodology (device, number of readings, time intervals) provide similar BP values. The pooled unattended‐attended OBP difference was −1.3/−0.4 mm Hg (systolic/diastolic) and 95% CI excluded a systolic OBP difference larger than 4.3 mm Hg and diastolic larger than 1.2 mm Hg. Thus, these data suggest that the difference between unattended and attended OBP is not clinically important as it is less than 5 mm Hg. These findings are in line with the SPRINT study results,6 yet different subjects were assessed with the two methods in that study.
If unattended automated OBP is compared with auscultatory OBP, then a significant BP difference is expected with the latter being higher due to its well‐known observer‐related issues.5 Moreover, if unattended automated OBP is compared with attended automated OBP but different number of BP readings is obtained with each method, again a BP difference is expected with lower BP levels when more OBP readings are obtained.15, 20 To demonstrate the net effect of “unattended” automated OBP, this should be compared with attended automated OBP but using the same device and in identical conditions and using identical protocol of measurements with the two methods, which is the specific methodology followed for selecting studies to be included in the present analysis.
The studies in this meta‐analysis suggest that when automated OBP measurements are taken under standardized conditions (resting period, at least triplicate measurements, no talking), the “presence” of the observer itself has minimal or no effect on measured OBP. It should be noted, however, that if attended OBP measurements are not standardized (eg, no resting period, single BP measurement, talking during measurements), which is not uncommon in routine clinical practice, then attended OBP will probably be higher than unattended OBP.
An interesting observation is that at higher OBP levels, attended automated OBP may be higher than unattended OBP (Figure 3), which is in line with the larger BP differences between office and ambulatory or home BP in subjects with higher OBP levels.35 However, these differences are more likely to alter therapeutic decisions in subjects with OBP levels close to the diagnostic thresholds for treatment decisions and less so in those with higher BP levels.
These findings should be interpreted in light of some limitations, the most important of which is the heterogeneity across the studies included. In order to compensate for the heterogeneity, random effects models, as well as sensitivity and stratified analyses were used. Moreover, it should be mentioned that all studies apart from one were of high quality. Last, these results are based on published summary statistics rather than raw data.
In conclusion, these data suggest that standardized attended automated OBP gives similar BP values as unattended automated OBP provided that the same standardized methodology is followed. OBP measurement remains the most evidence‐based method for hypertension evaluation and diagnosis, and despite the increasing use of out‐of‐office BP monitoring and its endorsement by hypertension societies, at present and for some time to come it is likely that in many people, the diagnosis and management of hypertension will be based on OBP measurement alone.1, 2 However, the methodological details of OBP measurement are crucial for extracting reliable conclusions.1, 2 Unattended automated OBP measurement has the advantage to ensure the avoidance of several sources of error (talking, no resting, single measurement, etc), yet it requires additional resources within a routine office visit (office space and additional time) and therefore cannot be implemented in all primary care settings. On the other hand, to obtain triplicate automated attended OBP measurement after few minutes rest is feasible for wide application in primary care. It is important to note that the latter is an evidence‐based method as in the last 20 years the vast majority of outcome studies in hypertension have used attended automated OBP measurements.36 National practice protocols should be developed for widespread implementation of standardized automated OBP measurement across primary care settings.
CONFLICT OF INTEREST
GSS has conducted validation studies of automated blood pressure measuring devices for various manufacturers and advised manufacturers on device development. The other authors have nothing to declare.
Supporting information
Kollias A, Stambolliu E, Kyriakoulis KG, Gravvani A, Stergiou GS. Unattended versus attended automated office blood pressure: Systematic review and meta‐analysis of studies using the same methodology for both methods. J Clin Hypertens. 2019;21:148–155. 10.1111/jch.13462
REFERENCE
- 1. Stergiou G, Kollias A, Parati G, O'Brien E. Office blood pressure measurement: The weak cornerstone of hypertension diagnosis. Hypertension. 2018;71:813‐815. [DOI] [PubMed] [Google Scholar]
- 2. Stergiou GS, Kyriakoulis KG, Kollias A. Office blood pressure measurement types: Different methodology — Different clinical conclusions. J Clin Hypertens. 2018;20:1683–1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta‐analyses, and meta‐regression analyses of randomized trials. J Hypertens. 2014;32:2285‐2295. [DOI] [PubMed] [Google Scholar]
- 4. Myers MG, Meglis G, Polemidiotis G. The impact of physician versus automated blood pressure readings on office‐induced hypertension. J Hum Hypertens. 1997;11:491‐493. [DOI] [PubMed] [Google Scholar]
- 5. Myers MG. A short history of automated office blood pressure‐15 years to SPRINT. J Clin Hypertens (Greenwich). 2016;18:721‐724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Johnson KC, Whelton PK, Cushman WC, et al. Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71:848‐857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Internal Med. 2011;155:529‐536. [DOI] [PubMed] [Google Scholar]
- 8. Critical Appraisal Skills Programme (CASP) . Cohort Study Checklist. UK: CASP; 2013. http://www.casp-uk.net/. Accessed September 8, 2018. [Google Scholar]
- 9. Higgins JPT, Cochrane Green S. Handbook for systematic reviews of interventions, Version 5.1.0. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org. Accessed June 18, 2016. [Google Scholar]
- 10. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088‐1101. [PubMed] [Google Scholar]
- 11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ. 1997;315:629‐634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Arifin WN. Calculating standard deviation of difference for determination of sample size for planned paired t‐test analysis. Education in Medicine Journal. 2014;6(2). 10.5959/eimj.v6i2.252. [DOI] [Google Scholar]
- 13. Holm L, Stucke‐Brander T, Wagner S, et al. Automated blood pressure self‐measurement station compared to office blood pressure measurement for first trimester screening of pre‐eclampsia. Health Informatics J. 2018. 10.1177/1460458218799505 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
- 14. Agarwal R. Implications of blood pressure measurement technique for implementation of systolic blood pressure intervention trial (SPRINT). J Am Heart Assoc. 2017;6(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Bhatnagar A, Pein U, Markau S, et al. Influence of SPRINT study type automated office blood pressure measurements on hypertension diagnosis in kidney transplant patients. Kidney Blood Press Res. 2018;43:310‐317. [DOI] [PubMed] [Google Scholar]
- 16. Siddiqui M, Judd EK, Oparil S, Calhoun DA. White‐coat effect is uncommon in patients with refractory hypertension. Hypertension. 2017;70:645‐651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Andreadis EA, Papademetriou V, Geladari CV, Kolyvas GN, Angelopoulos ET, Aronis KN. Home, automated office, and conventional office blood pressure as predictors of cardiovascular risk. J Am Soc Hypertens. 2017;11(3):165‐170.e2. [DOI] [PubMed] [Google Scholar]
- 18. Andreadis EA, Agaliotis GD, Angelopoulos ET, Tsakanikas AP, Kolyvas GN, Mousoulis GP. Automated office blood pressure is associated with urine albumin excretion in hypertensive subjects. Am J Hypertens. 2012;25:969‐973. [DOI] [PubMed] [Google Scholar]
- 19. Hong D, Su H, Li J, et al. The effect of physician presence on blood pressure. Blood Press Monit. 2012;17:145‐148. [DOI] [PubMed] [Google Scholar]
- 20. Myers MG, Valdivieso M. Evaluation of an automated sphygmomanometer for use in the office setting. Blood Press Monit. 2012;17:116‐119. [DOI] [PubMed] [Google Scholar]
- 21. Martin CA, Cameron JD, Chen SS, McGrath BP. Two hour glucose post loading: a biomarker of cardiovascular risk in isolated clinic hypertension. J Hypertens. 2011;29:749‐757. [DOI] [PubMed] [Google Scholar]
- 22. OʼShaughnessy MM, Newman CA, Kinsella SM, Reddan DN, Lappin DW. In‐office assessment of blood pressure in chronic kidney disease: usual measurement versus automated BpTRU measurement. Blood Press Monit. 2011;16:124‐128. [DOI] [PubMed] [Google Scholar]
- 23. Andreadis EA, Agaliotis GD, Angelopoulos ET, Tsakanikas AP, Chaveles IA, Mousoulis GP. Automated office blood pressure and 24‐h ambulatory measurements are equally associated with left ventricular mass index. Am J Hypertens. 2011;24:661‐666. [DOI] [PubMed] [Google Scholar]
- 24. Adiyaman A, Aksoy I, Deinum J, Staessen JA, Thien T. Influence of the hospital environment and presence of the physician on the white‐coat effect. J Hypertens. 2015;33:2245‐2249. [DOI] [PubMed] [Google Scholar]
- 25. Vinyoles E, Blancafort X, López‐Quiñones C, et al. Blood pressure measurement in an ambulatory setting: concordance between physician and patient self‐measurement. J Hum Hypertens. 2003;17:45‐50. [DOI] [PubMed] [Google Scholar]
- 26. Stergiou GS, Efstathiou SP, Alamara CV, Mastorantonakis SE, Roussias LG. Home or self blood pressure measurement? What is the correct term? J Hypertens. 2003;21:2259‐2264. [DOI] [PubMed] [Google Scholar]
- 27. Greiver M, White D, Kaplan DM, Katz K, Moineddin R, Dolabchian E. Where should automated blood pressure measurements be taken? Pilot RCT of BpTRU measurements taken in private or nonprivate areas of a primary care office. Blood Press Monit. 2012;17:137‐138. [DOI] [PubMed] [Google Scholar]
- 28. Al‐Karkhi I, Al‐Rubaiy R, Rosenqvist U, Falk M, Nystrom FH. Comparisons of automated blood pressures in a primary health care setting with self‐measurements at the office and at home using the Omron i–C10 device. Blood Press Monit. 2015;20:98‐103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Wang XX, Shuai W, Peng Q, et al. White coat effect in hypertensive patients: the role of hospital environment or physician presence. J Am Soc Hypertens. 2017;11:498‐502. [DOI] [PubMed] [Google Scholar]
- 30. Rinfret F, Cloutier L, Wistaff R, et al. Comparison of different automated office blood pressure measurement devices: evidence of nonequivalence and clinical implications. Can J Cardiol. 2017;33:1639‐1644. [DOI] [PubMed] [Google Scholar]
- 31. Bauer F, Seibert FS, Rohn B, et al. Attended versus unattended blood pressure measurement in a real‐life setting. Hypertension. 2018;71:243‐249. [DOI] [PubMed] [Google Scholar]
- 32. Andreadis EA, Geladari CV, Angelopoulos ET, Savva FS, Georgantoni AI, Papademetriou V. Attended and unattended automated office blood pressure measurements have better agreement with ambulatory monitoring than conventional office readings. J Am Heart Assoc. 2018;7:e008994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Paini A, Bertacchini F, Stassaldi D, et al. Unattended versus attended blood pressure measurement: Mean values and determinants of the difference. Int J Cardiol. 2019;274:305‐310. [DOI] [PubMed] [Google Scholar]
- 34. Papademetriou V, Tsioufis C, Chung A, Geladari C, Andreadis EA. Unobserved automated office BP is similar to other clinic BP measurements: a prospective randomized study. J Clin Hypertens (Greenwich). 2018;20:1411‐1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13‐e115. [DOI] [PubMed] [Google Scholar]
- 36. Giorgini P, Weder AB, Jackson EA, Brook RD. A review of blood pressure measurement protocols among hypertension trials: implications for “evidence‐based” clinical practice. J Am Soc Hypertens. 2014;8:670‐676. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
